Background When the COVID-19 vaccines arrived in Uganda in early March of 2021, there was a lack of information on the vaccine acceptance in the population due to many factors, mainly misinformation and disinformation circulating in the Ugandan social and mainstream media. This study aimed to determine factors associated with COVID-19 vaccine acceptance among the adult population in northern Uganda. Methods We conducted a cross-sectional study among the 723-adult population in northern Uganda. Participants were selected randomly from the nine districts of the Acholi sub-region. Ethical approval was obtained from a local IRB, and SPSS version 20.0 was used for data analysis at a multivariable logistic regression. A p-value less than 0.05 was considered significant. Results The most significant finding was that COVID-19 vaccine acceptance among the adult population in northern Uganda was at 580/723(80.22%) and was significantly associated with those with comorbidities AoR = 0.397, 95%CI: 0.233,0.674; p = 0.001; those who agreed that vaccines in health facilities in northern Uganda were safe AoR = 0.724, 95%CI:0.597,0.878;p = 0.001; graduates AoR = 2.781,95%CI:1.278,6.052;p = 0.010; females AoR = 0.616, 95%CI:0.396,0.957; p = 0.031; Catholics AoR = 1.703,95%CI:1.048,2.765;p = 0.032; Baganda tribe AoR = 3.829,95%CI:1.170,7.790;p = 0.026; non-smokers AoR = 7.349,95%CI:1.767,30.566;p = 0.006; ex-smokers AoR = 8.687,95%CI:1.052,71.734;p = 0.045; Agago district AoR = 2.950,95%CI: 1.118,7.789; p = 0.029, and Lamwo district AoR = 2.781, 95%CI:1.278,6.052; p = 0.010. Conclusion COVID-19 vaccine acceptance among the study population was encouragingly high despite the disinformation and misinformation in the Ugandan media. The independent determinants of COVID-19 vaccine acceptance were among females, those who agreed that vaccines in health facilities were safe, those with comorbidities, graduates, Catholics, Baganda tribe, ex-smokers and non-smokers, and participants from Agago and Lamwo districts. The fear of contracting the coronavirus and the fear of death if not vaccinated contributed significantly to the COVID-19 vaccine acceptance in northern Uganda. There is a need for health managers to engage, sensitize and mobilize the population on the COVID-19 vaccine and vaccination using the VHTs and the catholic church structures, which remain critically important for the vaccination campaign if the high COVID-19 vaccine acceptance in the sub-region is to be maintained or improved.
BackgroundThe advent of the novel coronavirus disease 2019 (COVID-19) has caused millions of deaths worldwide. As of December 2021, there is inadequate data on the outcome of hospitalized patients suffering from COVID-19 in Africa. This study aimed at identifying factors associated with hospital mortality in patients who suffered from COVID-19 at Gulu Regional Referral Hospital in Northern Uganda from March 2020 to October 2021.MethodsThis was a single-center, retrospective cohort study in patients hospitalized with confirmed SARS-CoV-2 at Gulu Regional Referral Hospital in Northern Uganda. Socio-demographic characteristics, clinical presentations, co-morbidities, duration of hospital stay, and treatments were analyzed, and factors associated with the odds of mortality were determined.ResultsOf the 664 patients treated, 661 (99.5%) were unvaccinated, 632 (95.2%) recovered and 32 (4.8%) died. Mortality was highest in diabetics 11 (34.4%), cardiovascular diseases 12 (37.5%), hypertensives 10 (31.3%), females 18 (56.3%), ≥50-year-olds 19 (59.4%), no formal education 14 (43.8%), peasant farmers 12 (37.5%) and those who presented with difficulty in breathing/shortness of breath and chest pain 32 (100.0%), oxygen saturation (SpO2) at admission <80 4 (12.5%), general body aches and pains 31 (96.9%), tiredness 30 (93.8%) and loss of speech and movements 11 (34.4%). The independent factors associated with mortality among the COVID-19 patients were females AOR = 0.220, 95%CI: 0.059–0.827; p = 0.030; Diabetes mellitus AOR = 9.014, 95%CI: 1.726–47.067; p = 0.010; Ages of 50 years and above AOR = 2.725, 95%CI: 1.187–6.258; p = 0.018; tiredness AOR = 0.059, 95%CI: 0.009–0.371; p < 0.001; general body aches and pains AOR = 0.066, 95%CI: 0.007–0.605; p = 0.020; loss of speech and movement AOR = 0.134, 95%CI: 0.270–0.660; p = 0.010 and other co-morbidities AOR = 6.860, 95%CI: 1.309–35.957; p = 0.020.ConclusionThe overall Gulu Regional Hospital mortality was 32/664 (4.8%). Older age, people with diabetics, females, other comorbidities, severe forms of the disease, and those admitted to HDU were significant risk factors associated with hospital mortality. More efforts should be made to provide “additional social protection” to the most vulnerable population to avoid preventable morbidity and mortality of COVID-19 in Northern Uganda.
Background The ongoing COVID-19 pandemic has significantly impacted the physical and mental health of the general population worldwide, with healthcare workers at particular risk. The pandemic's effect on healthcare workers' mental well-being has been characterized by depression, anxiety, work-related stress, sleep disturbances, and post-traumatic stress disorder. Hence, protecting the mental well-being of healthcare workers (HCWs) is a considerable priority. This review aimed to determine risk factors for adverse mental health outcomes and protective or coping measures to mitigate the harmful effects of the COVID-19 crisis among HCWs in sub-Saharan Africa. Methods We performed a literature search using PubMed, Google Scholar, Cochrane Library, and Embase for relevant materials. We obtained all articles published between March 2020 and April 2022 relevant to the subject of review and met pre-defined eligibility criteria. We selected 23 articles for initial screening and included 12 in the final review. Result A total of 5,323 participants in twelve studies, predominantly from Ethiopia (eight studies), one from Uganda, Cameroon, Mali, and Togo, fulfilled the eligibility criteria. Investigators found 16.3–71.9% of HCWs with depressive symptoms, 21.9–73.5% with anxiety symptoms, 15.5–63.7% experienced work-related stress symptoms, 12.4–77% experienced sleep disturbances, and 51.6–56.8% reported PTSD symptoms. Healthcare workers, working in emergency, intensive care units, pharmacies, and laboratories were at higher risk of adverse mental health impacts. HCWs had deep fear, anxious and stressed with the high transmission rate of the virus, high death rates, and lived in fear of infecting themselves and families. Other sources of fear and work-related stress were the lack of PPEs, availability of treatment and vaccines to protect themselves against the virus. HCWs faced stigma, abuse, financial problems, and lack of support from employers and communities. Conclusion The prevalence of depression, anxiety, insomnia, and PTSD in HCWs in sub-Saharan Africa during the COVID-19 pandemic has been high. Several organizational, community, and work-related challenges and interventions were identified, including improvement of workplace infrastructures, adoption of correct and shared infection control measures, provision of PPEs, social support, and implementation of resilience training programs. Setting up permanent multidisciplinary mental health teams at regional and national levels to deal with mental health and providing psychological support to HCWs, supported with long-term surveillance, are recommended.
Background Ever since the appearance of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease (COVID-19) in Wuhan in mid-December 2019, its spread has been dramatic worldwide. It became apparent that the number of pediatric COVID-19 patients was much lower than in adults. Variable clinical presentations and progression have characterized morbidity and mortality in children and young adults. Objective The objective of this study was to assess the characteristics of the COVID-19 among children and adolescents below 20 years in Northern Uganda and determine factors associated with treatment outcomes in the study population. Materials and Methods A cross-sectional study conducted a retrospective data abstraction of the COVID-19 patients registered in the Gulu Hospital Health Management Information System (HMIS) database and other tools. The study covered the period between March 2020 and October 2021. Data that met the inclusion criteria were consecutively extracted from the Gulu Hospital HMIS database. A local IRB approved the study. SPSS version 25.0 was used for data analysis, and a p-value less than 0.05 was considered significant. Results There were 41 COVID-19 patients below 20 years among the 664 total COVID-19 patient population, constituting 41/664(6.2%) of the total COVID-19 patients treated at Gulu Regional Referral Hospital from March 2020 to October 2021. The median age was 19 years (ranging from 13 to 20 years), the mean age was 18.2 years SD±1.95 at 95% CI:17.51-18.74. Females constituted 58.5% of the study population. The mean duration of hospital stay was 14.44 days SD±10.45 at 95% CI:11.14-17.74, and the mean duration of symptoms at admission was 7.96 days SD±7.38 at 95% CI:4.84-11.07. The comorbidities were cardiovascular diseases 3/41(7.3%) and hypertension 3/41(7.3%) and were not in the same patients. Pneumonia 1/41(3.3%) and acute liver injury 1/41(3.3%) were the observed complications. The morbidity and mortality rates were 2/41(4.9%) and 0/41(0.0%), respectively. Participants’ symptoms, signs, complications, and comorbidities by gender were not statistically significant. Conclusion Data showed excellent treatment outcomes of the COVID-19 among children and adolescents below 20 years in Northern Uganda with a recovery rate of 100.0%. The burden of symptoms of the illness, comorbidities, and complications was fewer. There is a need to conduct more extensive studies on the role played by age in the successful recovery of COVID-19 patients, even in a low-resource milieu.
Background: The advent of the novel coronavirus disease 2019 (COVID-19) has caused millions of deaths worldwide. There is a lack of data on the outcome of hospitalized African patients suffering from COVID-19.This study aimed at identifying factors associated with hospital mortality in patients who suffered from COVID-19 at Gulu Regional Referral Hospital in Northern Uganda from March 2020 to October 2021.Methods: This was a single-center, retrospective study in patients hospitalized with confirmed COVID-19 at Gulu Regional Referral Hospital in Northern Uganda. Socio-demographic characteristics, clinical presentations, comorbidities, duration of hospital stay, and treatment were analyzed, and factors associated with increased odds of mortality were determined.Results: Of the 664 patients treated, 661(99.5%) were unvaccinated, 632(95.2%) recovered and 32(4.8%) died. Mortality was highest in diabetics 11(34.4%), cardiovascular diseases 12(37.5%), hypertensive 10(31.3%), females 18(56.3%), > 50-year-olds 19(59.4%), no formal education 14(43.8%), peasant farmers 12(37.5%) and those who presented with difficulty in breathing/shortness of breath and chest pain 32(100.0%), Oxygen saturation (Sp02) <80 4(12.5%), general body aches and pains 31(96.9%), tiredness 30(93.8%) and loss of speech and movements 11(34.4%). The independent factors associated with mortality among the COVID-19 patients were females AOR=0.220,95%CI:0.059-0.827;p=0.030; Diabetes mellitus AOR=9.014, 95%CI:1.726-47.067;p=0.010; tiredness AOR=0.059,95%CI:0.009-0.371; p=0.0000; general body aches and pains AOR=0.066,95%CI:0.007-0.605; p=0.020; loss of speech and movement AOR=0.134,95%CI:0.270-0.660;p=0.010 and other comorbidities AOR=6.860, 95%CI:1.309-35.957;p=0.020.Conclusion: The overall hospital mortality was 4.8%. Older age, people with diabetics, females, other comorbidities, severe forms of the disease, and those admitted to HDU were significant risk factors associated with hospital mortality. More efforts should be made to provide “Enhanced shielding” to the most vulnerable population to avoid preventable morbidity and mortality of COVID-19 in Northern Uganda.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.